Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes

@inproceedings{Mohammedi2017ComparativeEO,
  title={Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes},
  author={Kamel Mohammedi and Mark Woodward and Michel Marre and Stephen Colagiuri and Mark Emmanuel Cooper and Stephen Brian Harrap and Giuseppe Mancia and Neil R. Poulter and Bryan P Williams and S Zoungas and John Chalmers},
  booktitle={Cardiovascular diabetology},
  year={2017}
}
BACKGROUND Microvascular disease is associated with a high risk of macrovascular events in patients with type 2 diabetes, but the impact of macrovascular disease on the risk of microvascular events remains unknown. We sought to evaluate the respective effects of prior microvascular and macrovascular disease on the risk of major outcomes, including microvascular events, in these patients. METHODS Participants in the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified… CONTINUE READING